Social implications and perceptions of the urban Indian population in the current scenario of COVID-19: a comprehensive survey

Dayanand M. Kannur, Suvarna P. Ingale, Digambar B. Ambikar, Dhruvi A. Gosar, Shubham V. Pawar, Anagha M. Joshi, Pallavi S. Sajanapwar


Background: The goal of this questionnaire is to understand the social implications and the knowledge urban populations has about COVID 19, and are people are taking proper precautions against the disease.

Methods: Since there is no proven validated vaccine for prevention of COVID 19 to date, isolation of high-risk individuals and social distancing is the only solution to limit the spread. Since the government of India imposed the national lockdown on 22 March. A cross-sectional questionnaire-based study was carried out by dispensing the questionnaire to individuals through online mode. A total of 633 responses were collected from individuals by a pre-designed. In our study we studied the knowledge of the Indian population about COVID 19. 64.8 % reported that they are well versed in the details of the pandemic COVID 19. More than 94 % of individuals stated that they are properly prepared and are taking proper precautions. Moreover approximately 95% of the population feels the seriousness about COVID 19 increased after lockdown. The majority of people are aware of the measures to be taken for avoiding transmission of COVID 19 infection. But some people are still not aware of the precautions to be taken to avoid the spread of the disorder.

Conclusions: Along with isolation and social distancing, creating awareness about the disease by educating the people about COVID 19 is also important. Physical health taking care of the mental health of individuals is equally important.


Coronavirus, COVID 19, Mental health, Social distancing

Full Text:



WHO. Coronavirus disease (COVID-2019) situation reports. 2020. Available at: emergencies/diseases/novel-coronavirus 2019/situationreports. Accessed on 29 April 2020.

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74.

Ministry of health and family welfare, 2020. Available at: Accesses on 29 April 2020.

Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;8:45-8.

Lee PI, Hsueh PR. Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV. J MicrobiolImmunol Infect. 2020;8:95-106.

Zheng Yan. Unprecedented pandemic, unprecedented shift, and unprecedented opportunity. Hum Behav and Emerg Tech. 2020;7:1-3

Ellemarije A, Chiara B, Jason GE, Dimitri G, Lukas F, Dieter R. dealing with sleep problems during home confinement due to COVID 19 outbreak: Practical recomandations from a task force of the Europian CBT I academy. J of sleep Res 2020.

Kim U, Navjot B, Debra J. Life in the pandemic: Social isolation and mental health. J of clinical Nursing. Accessed on 29 April 2020.

Perrin PC, McCabe OL, Everly GS Jr, Links JM. Preparing for an influenza pandemic: Mental health considerations. Prehosp Disaster Med. 2009;24(3):223-30.

Streiner DL, Norman GR, Cairney J. Health measurement scales: A practical guide to their development and use: Oxford university press; 2014.

WHO. COVID-19 strategy update. Available at: Accessed on 14 April 2020.

WHO. Critical preparedness, readiness and response actions for COVID-19. Interim guidance 22 March 2020. Accessed on 20 August 2020.

WHO, Coronavirus disease 2019 (COVID-19) Situation Report. Available at: https://www. coronaviruse/situation-reports/20200419-sitrep-90-covid19.pdf?sfvrsn= 551d47fd_4. Accessed on 20 August 2020.

WHO. Novel Coronavirus (2019-nCoV) situation report. Available at default-source/coronaviruse/situation-reports/ 20200121-sitrep-1-2019-ncov.pdf?sfvrsn =20a99c10_4. Accessed on 20 August 2020.

Zheng SQ, Yang L, Zhou PX, Li HB, Liu F, Zhao RS. Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm. 2020;S1551-7411(20):30284-9.

Pharmacist in covid. Available at Accessed on 20 August 2020.

Mahapatra T. Self-care and self-medication: A commentary. Ann Trop Med Public Health. 2017;10:505-6.

Shaghaghi A, Asadi M, Allahverdipour H. Predictors of self-medication behavior: A systematic review. Iran J Public Health 2014;43:136-46.

ICMR. Available at https:// www. The Accessed on 20 August 2020.

Thapa S, Shankar PR, Palaian S, Aljadhey H. Promoting rational self-medication of nonsteroidal anti-inflammatory drugs in Nepal. Arch Pharma Pract. 2016;7:61-6.

BMJ. Covid-19: NICE advises against using NSAIDs for fever in patients with suspected cases BMJ 2020. Available at bmj.m1409. Accessed on 20 August 2020.

Fang L, Karakiulakis G, Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? 2020;8(4):116.

NSAIDS. Available at https:// drugs/drug-safety-and-availability/fda-advises-patients-use-non-steroidal-anti-inflammatory-drugs-nsaids-covid-19. Accessed on 20 August 2020.

Yang X, Yu Y, Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020;2600(20)30079-5.

Guan W, Ni Z, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;7:23-9.

Zhang JJ, Dong X, Cao YY. Clinical characteristics of 140 patients infected by SARS-CoV-2 in Wuhan, China. Allergy. 2020;3:76-9.